Among the glycolytic genes, we found the down-regulation of MPC1 (BRP44L), and the up-regulation of HK2 and GPI in prostate cancer, which also showed similar dysregulation patterns in other types of cancers (Supplementary Figure S1). The gene discussed is MPC1; the disease is prostate carcinoma.